Life Sciences
Regulated procurement breaks at the handoffs.
For pharma, medtech and animal-health organizations where procurement, S2P/P2P, shared services and ERP governance carry regulatory weight. KULIC Advisory names where execution breaks, before the next system, program or committee gets funded.
Master system
One system. Every engagement.
Execution Architecture™ and Human-Centered Execution™ connect process, ownership, governance, technology and leadership rhythm into one operating system.
SIGNAL OVER NOISE. SYSTEM OVER EGO.Engagement file
Four named environments. One record.
PERSONALLY DELIVERED · DOCUMENTED FROM THE ENGAGEMENT FILEAnimal Health, lived end to end.
Three years at Elanco as Global Process Owner & Director P2P and Procurement PMO:
- ▸Stabilization lead for the carved-out Bayer Animal Health business: shared services, accounts payable, P2P, supplier master data, controls and governance.
- ▸Transformation change agent for 4,000+ employees across 40+ countries.
- ▸P2P organisation from 30 to 17 experts, carried by a global power-user model: 130 power users and 35 captains in 35 countries, rolled out in three months.
- ▸Owner of 12 P2P SoX controls; data domain owner for SAP purchasing contracts.
- ▸Top Performance Awards 2020 and 2021; Voice-of-the-Employee score Q3/22 around 25% above company average on participation and engagement.
Pharma sourcing with a named outcome.
- ▸Project procurement lead for strategic sourcing and project management of laboratory-scale devices in the pharma division.
- ▸EUR 1,000,000 savings, a career outcome from a named environment, personally delivered and documented from the engagement file.
- ▸Held as career evidence; the underlying documentation stays confidential.
Pharma procurement, client-evaluated.
- ▸Senior consultant for indirect procurement across CAPEX, OPEX, facility, maintenance, services and spare parts, with direct links to the Novartis integration.
- ▸Interim mandate as global sourcing category manager for secondary process equipment.
- ▸Mission evaluated by the client's director of indirect procurement; award for the best procurement consulting performance on the engagement.
- ▸Award for best project management in real-estate and facility projects; advisor to the purchasing director on Novartis acquisition synergies.
- ▸The portfolio closed EUR 1.5M under budget : the Class A reference case.
Group-wide S2P architecture, by mandate.
- ▸Architect of the end-to-end source-to-pay process across the entire Merck Group.
- ▸Governance architecture for the end-to-end process.
- ▸Blueprint for the GPO S2P role archetype in group procurement.
- ▸The most recent named environment in this record: S2P execution architecture at group level.
Evidence class on every claim.
Every public figure carries its evidence class. The class names the document type:
- AClass A: validated reference case shown on the central proof page. GSK Vaccines Belgium 2015, closed EUR 1.5M under approved budget.
- KCareer evidence: Bayer Pharma 2019, a career outcome from a named environment, personally delivered.
- BClass B: implemented outcomes. S/4HANA outline agreement control; USD 450K reported cost avoidance; reported P2P cost reduction of USD 1M+.
- CClass C: modeled value potential. Around 4M USD modeled AICTIONBOT™ value potential.
- DClass D: effort signal supporting the Class C model.
A documented career.
These are employment and engagement contexts from a documented, publicly verifiable life-sciences career. Published proof cases stay deliberately industry-neutral; ongoing client relationships stay confidential. Every case is personally delivered and documented from the engagement file.
Work artifact
The source-to-pay metro map.
END-TO-END S2P · FROM PRACTICENot a stock graphic. A real work artifact from practice: the end-to-end S2P process landscape drawn as a transit map, so executives and process owners can argue over the same picture.
Recognisable contexts, one practitioner pattern. Named environments such as GSK, Merck, Elanco and Bayer, including a GSK Vaccines Belgium recognition for strategic sourcing, stakeholder management, cost reduction and value engineering, reflect professional experience, advisory exposure, employment, speaking, board or transformation contexts. Ongoing client relationships stay confidential. Full context on the About page.
THE NEXT STEP
The smallest serious next step: the free Execution Signal Assessment™, an Executive Diagnosis, or purchase through your procurement process via the Enterprise buying path.
Executive Second Look™ €99 · Value Snapshot™ €149 · Executive Diagnosis €1,700 · System Review €2,500
Signal over noise. System over ego.